Lixte Biotechnology
LIXT
LIXT
7 hedge funds and large institutions have $409K invested in Lixte Biotechnology in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FIA
1
FNY Investment Advisers
New York
|
$139K |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$33.5K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$686 |
Top Sellers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$3.95K |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$30 |